Observational studyBioscience reports2020

MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.

Tingting Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.